Moxilin-CV Tablet 875 mg + 125 mg combines Amoxicillin Trihydrate, a potent broad-spectrum penicillin antibiotic, with Clavulanic Acid, a beta-lactamase inhibitor. This combination enhances the efficacy of amoxicillin by protecting it from degradation by beta-lactamase–producing bacteria, making it highly effective against resistant strains. Moxilin-CV is formulated for the treatment of moderate to severe bacterial infections requiring robust antibacterial therapy.

Amoxicillin acts by inhibiting bacterial cell wall synthesis, causing structural weakness and bacterial cell death. Clavulanic Acid, while not significantly antibacterial on its own, prevents certain bacteria from inactivating amoxicillin, thus restoring its activity. The combination offers broad-spectrum coverage, ensuring effective treatment of infections caused by both penicillin-sensitive and beta-lactamase–producing bacteria.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Indications

Moxilin-CV Tablet 875 mg + 125 mg is indicated for the treatment of infections caused by susceptible bacteria, including:

• Upper respiratory tract infections, including sinusitis, pharyngitis, and tonsillitis

• Lower respiratory tract infections, such as bronchitis and pneumonia

• Acute otitis media (middle ear infection)

• Skin and soft tissue infections

• Urinary tract infections

• Dental infections, including abscesses

• Infections caused by beta-lactamase–producing bacteria resistant to amoxicillin alone

This higher-strength formulation is particularly suitable for more severe infections or infections caused by resistant organisms.

Dosage and Administration

The usual adult dosage is one tablet of 875 mg + 125 mg every 12 hours, or as directed by a healthcare professional. The tablet should be swallowed whole with an adequate amount of water. It can be taken with or without food, although taking it with food may help reduce gastrointestinal discomfort.

Pediatric dosing is determined by body weight and infection severity and should only be administered under the supervision of a healthcare professional. Completing the full prescribed course is critical, even if symptoms improve before finishing the medication, to prevent recurrence and reduce the risk of antibiotic resistance.

Precautions and Warnings

• Contraindicated in patients with hypersensitivity to penicillins, cephalosporins, or clavulanic acid.

• Use cautiously in patients with a history of liver disease or jaundice.

• Prolonged use may result in superinfections due to resistant organisms.

• Patients with renal impairment may require dosage adjustments.

• Inform the physician about all current medications to avoid potential drug interactions.

• Use during pregnancy or lactation only if clearly necessary and prescribed by a healthcare professional.

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Side Effects

Moxilin-CV Tablet 875 mg + 125 mg is generally well tolerated. Common side effects may include:

• Nausea and vomiting

• Diarrhea

• Mild abdominal discomfort

• Skin rash or itching

Rare but serious adverse effects may include severe allergic reactions, liver enzyme abnormalities, or antibiotic-associated colitis. Immediate medical attention is required if symptoms such as difficulty breathing, swelling of the face or throat, or severe rash occur.

Storage

Store below 30°C in a cool, dry place, protected from light and moisture. Keep out of reach of children.

Moxilin-CV Tablet 875 mg + 125 mg provides powerful broad-spectrum antibacterial therapy, including coverage against beta-lactamase–producing bacteria, ensuring effective treatment for moderate to severe infections under proper medical supervision.